Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer's Disease.

AD Alzheimer’s disease SOD2 genetics oxidative stress rs4880 variant

Journal

Current issues in molecular biology
ISSN: 1467-3045
Titre abrégé: Curr Issues Mol Biol
Pays: Switzerland
ID NLM: 100931761

Informations de publication

Date de publication:
21 Sep 2022
Historique:
received: 02 08 2022
revised: 16 09 2022
accepted: 16 09 2022
entrez: 26 10 2022
pubmed: 27 10 2022
medline: 27 10 2022
Statut: epublish

Résumé

A few gene loci that contribute to Alzheimer's Disease (AD) onset have been identified. Few studies have been published about the relationship between SOD2 rs4880 single nucleotide variant and AD, revealing inconsistent results. Therefore, the aim of the current study is to further examine the role of the SOD2 rs4880 in AD. We performed a case-control study with a total of 641 subjects (320 patients with probable AD, and 321 healthy controls). The statistical analysis was performed assuming five genetic models. The threshold for statistical significance was set at 0.05. The results revealed no association between SOD2 rs4880 and AD in any of the assumed genetic models that were examined [log-additive OR = 0.95 (0.76-1.19), over-dominant OR = 1.15 (0.85-1.57), recessive OR = 0.85 (0.59-1.22), dominant OR = 1.03 (0.72-1.47), and co-dominant OR1 = 1.10 (0.75-1.60) and OR2 = 0.90 (0.58-1.40)]. Adjustment for sex and subgroup analyses based on sex did not reveal any statistically significant results either. Based on our findings, SOD2 rs4880 does not appear to play a determining role in the risk of developing AD. Larger studies are warranted to elucidate the connection between rs4880 and AD.

Identifiants

pubmed: 36286017
pii: cimb44100302
doi: 10.3390/cimb44100302
pmc: PMC9600469
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4406-4414

Subventions

Organisme : Research Committee of the University of Thessaly, Greece
ID : (code: 5287)

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Exp Hematol. 2013 Mar;41(3):316-21
pubmed: 23142655
Exp Neurobiol. 2015 Dec;24(4):325-40
pubmed: 26713080
J Mol Neurosci. 2019 Oct;69(2):343-350
pubmed: 31267315
J Biol Chem. 2003 Apr 11;278(15):13294-301
pubmed: 12551919
Pharmacogenet Genomics. 2005 May;15(5):311-9
pubmed: 15864132
Nat Genet. 1995 Dec;11(4):376-81
pubmed: 7493016
Nat Genet. 2022 Apr;54(4):412-436
pubmed: 35379992
J Biol Chem. 2015 Sep 11;290(37):22805-17
pubmed: 26231211
Neurology. 2018 Jan 16;90(3):126-135
pubmed: 29282327
Neurol Res. 2020 Oct;42(10):853-861
pubmed: 32627711
Handb Clin Neurol. 2019;167:231-255
pubmed: 31753135
Environ Res. 2019 Oct;177:108632
pubmed: 31434017
Antioxid Redox Signal. 2011 Sep 15;15(6):1583-606
pubmed: 21473702
Exp Physiol. 1997 Mar;82(2):291-5
pubmed: 9129943
Apoptosis. 2017 Jan;22(1):1-26
pubmed: 27815720
J Alzheimers Dis. 2010;20 Suppl 2:S357-67
pubmed: 20421690
Can J Neurol Sci. 2012 Jul;39(4):436-45
pubmed: 22728850
Int J Biochem Cell Biol. 2007;39(1):44-84
pubmed: 16978905
J Bioenerg Biomembr. 2017 Aug;49(4):325-333
pubmed: 28616679
Curr Alzheimer Res. 2016;13(9):952-63
pubmed: 26971934
Neurologia. 2017 Oct;32(8):523-532
pubmed: 27130306
J Neurosci. 2009 Jul 15;29(28):9090-103
pubmed: 19605646
Free Radic Biol Med. 2000 Aug;29(3-4):222-30
pubmed: 11035250
J Mol Neurosci. 2020 Jun;70(6):851-860
pubmed: 32088842
Gene. 2012 Jun 15;501(2):89-103
pubmed: 22525041
Cell. 2006 Jun 30;125(7):1241-52
pubmed: 16814712
Curr Pharm Des. 2010;16(25):2766-78
pubmed: 20698820
J Alzheimers Dis. 2017;57(2):331-352
pubmed: 28269778
Lancet Neurol. 2021 Jan;20(1):68-80
pubmed: 33340485
Acta Neurol Scand. 2022 Feb;145(2):223-228
pubmed: 34694630
Dis Markers. 2015;2015:746329
pubmed: 26696693
J Integr Neurosci. 2022 Jan 28;21(1):32
pubmed: 35164468
Genes Brain Behav. 2007 Nov;6(8):770-5
pubmed: 17376152
Mol Med Rep. 2022 Apr;25(4):
pubmed: 35234271
FEBS J. 2018 Mar;285(6):995-1011
pubmed: 29148236
Acta Neuropathol. 2015 Sep;130(3):315-31
pubmed: 26210990
Curr Top Microbiol Immunol. 2018;414:131-157
pubmed: 28864830
Adv Pharmacol. 2012;64:83-126
pubmed: 22840745
Biomed Res Int. 2019 Jun 16;2019:9171424
pubmed: 31317043
Am J Clin Nutr. 2000 Feb;71(2):621S-629S
pubmed: 10681270
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Free Radic Biol Med. 2002 Aug 1;33(3):337-49
pubmed: 12126755
Curr Issues Mol Biol. 2021 May 26;43(1):197-214
pubmed: 34073287
Bioinformatics. 2006 Aug 1;22(15):1928-9
pubmed: 16720584
Cell Death Differ. 2006 Mar;13(3):374-84
pubmed: 16397578
Front Biosci (Elite Ed). 2013 Jan 01;5(1):167-77
pubmed: 23276979
Toxicol Lett. 2020 Jun 15;326:31-51
pubmed: 32145396
Br Med Bull. 1993 Jul;49(3):577-87
pubmed: 8221024
Pharmacogenet Genomics. 2006 Apr;16(4):279-86
pubmed: 16538174
J Integr Neurosci. 2020 Jun 30;19(2):321-332
pubmed: 32706196
Neurol Neurochir Pol. 2014;48(5):342-5
pubmed: 25440013
Am J Physiol Lung Cell Mol Physiol. 2000 Dec;279(6):L1005-28
pubmed: 11076791
Subcell Biochem. 2012;65:329-52
pubmed: 23225010

Auteurs

Vasileios Siokas (V)

Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Polyxeni Stamati (P)

Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Georgia Pateraki (G)

Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Ioannis Liampas (I)

Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Athina-Maria Aloizou (AM)

Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Daniil Tsirelis (D)

Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Anastasia Nousia (A)

Department of Speech and Language Therapy, University of Ioannina, 45500 Ioannina, Greece.

Markos Sgantzos (M)

Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Grigorios Nasios (G)

Department of Speech and Language Therapy, University of Ioannina, 45500 Ioannina, Greece.

Dimitrios P Bogdanos (DP)

Department of Rheumatology and Clinical Immunology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Efthimios Dardiotis (E)

Laboratory of Neurogenetics, Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.

Classifications MeSH